The Ordinary Salicylic Acid 2% Anhydrous Solution
Clear clogged pores and reduce breakouts with The Ordinary Salicylic Acid 2% Anhydrous Solution (30ml)—a water-free exfoliating serum that targets acne, blackheads, and uneven texture. Ideal for oily and acne-prone skin in Bangladesh.
The Ordinary Salicylic Acid 2% Anhydrous Solution is a gentle yet effective exfoliating serum designed to unclog pores, reduce acne, and smooth bumpy skin. Formulated in a water-free base, it delivers salicylic acid more efficiently while minimizing irritation—making it ideal for beginners or those sensitive to traditional acid formulas.
This serum targets blackheads, whiteheads, excess oil, and congestion by dissolving trapped sebum deep inside pores. Its lightweight, non-greasy texture makes it suitable for daily use, especially for oily, combination, and acne-prone skin types.
Perfect for anyone looking for an acne solution in Bangladesh, a blackhead-removing serum, or a gentle BHA option that doesn’t dry out the skin.
Key Benefits:
-
Unclogs pores and reduces acne breakouts
-
Targets blackheads, whiteheads, and congestion
-
Water-free formula for reduced irritation
-
Smooths rough, uneven texture
-
Controls excess oil for a clearer, fresher look
-
Suitable for oily, combination, and acne-prone skin
Key Ingredients:
-
Salicylic Acid 2%: A powerful BHA that penetrates pores to dissolve oil and impurities.
-
Squalane & Emollients: Help prevent dryness and irritation while maintaining skin balance.
How to Use:
-
Apply a few drops to clean, dry skin in the evening.
-
Use 2–3 times a week, or as tolerated.
-
Avoid using with other strong acids, retinoids, or exfoliants in the same routine.
-
Always apply sunscreen during the day when using exfoliating products.
Who Should Use It:
-
Those dealing with acne, blackheads, or textured skin
-
Oily or combination skin types
-
People looking for a gentle BHA exfoliant
-
Beginners who find traditional salicylic acid products too harsh
Reviews
There are no reviews yet.

Reviews
There are no reviews yet.